23P Combination chemotherapy and hormone therapy (CHT) in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): A single-centre retrospective analysis.
In: Annals of Oncology, Jg. 33 (2022-11-02), S. S1439
Online
academicJournal
Zugriff:
Titel: |
23P Combination chemotherapy and hormone therapy (CHT) in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (MBC): A single-centre retrospective analysis.
|
---|---|
Autor/in / Beteiligte Person: | Bajaj, K. ; Vora, D.N. ; Parab, P. ; Shaikh, H. ; Gulia, S. ; Rath, S. ; Bajpai, J. ; Shet, T. ; Desai, S. ; Popat, P. ; Rajan, R. ; Nair, N.S. ; Joshi, S. ; Pathak, R. ; Sarin, R. ; Kembhavi, Y. ; Rane, S. ; Ghosh, J. ; Badwe, R.A. ; Gupta, S. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 33 (2022-11-02), S. S1439 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2022.10.032 |
Schlagwort: |
|
Sonstiges: |
|